Literature DB >> 2161651

Characterization of a dose-response curve for nicotine-induced conditioned taste aversion in rats: relationship to elevation of plasma beta-endorphin concentration.

R A Jensen1, D G Gilbert, C J Meliska, T A Landrum, A B Szary.   

Abstract

In the first experiment a conditioned taste aversion paradigm was used to characterize a dose-response curve for the aversive properties of nicotine in male Sprague-Dawley rats. Doses of nicotine ranging from 0.01 to 0.46 mg/kg, 2.0 ml of 0.47 M lithium chloride, or saline were injected, ip, 10 min after exposure to a novel saccharin solution. Amount of saccharin consumed in a two-bottle test was assessed 72 h later. Nicotine doses of 0.046 mg/kg and above produced a significant degree of conditioned taste aversion. In a second experiment, four groups of 10 rats each were injected with saline, 0.022 mg/kg nicotine, 0.46 mg/kg nicotine, or 2.0 ml 0.47 of M LiCl. Doses of 0.46 mg/kg nicotine and 0.47 M LiCl elevated plasma beta-endorphin concentrations significantly above saline control values. The 0.022 mg/kg dose, the highest dose that did not produce conditioned taste aversion in Experiment 1, did not significantly increase plasma beta-endorphin concentrations. This finding suggests that doses of nicotine that produce conditioned taste aversion also promote the release of pituitary stress hormones. Taken together these data suggest that some of the pharmacological and behavioral effects attributed to nicotine, including the release of endogenous neuromodulators, may be dose-dependent concomitants of the aversive effects of nicotine in nicotine-naive animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2161651     DOI: 10.1016/0163-1047(90)90310-3

Source DB:  PubMed          Journal:  Behav Neural Biol        ISSN: 0163-1047


  7 in total

1.  Role of α5* nicotinic acetylcholine receptors in the effects of acute and chronic nicotine treatment on brain reward function in mice.

Authors:  Christie D Fowler; Luis Tuesta; Paul J Kenny
Journal:  Psychopharmacology (Berl)       Date:  2013-08-20       Impact factor: 4.530

2.  Effect of the selective kappa-opioid receptor antagonist JDTic on nicotine antinociception, reward, and withdrawal in the mouse.

Authors:  K J Jackson; Frank Ivy Carroll; S S Negus; M I Damaj
Journal:  Psychopharmacology (Berl)       Date:  2010-03-16       Impact factor: 4.530

3.  Naloxone precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Vernonia cinerea Less. supplementation and strenuous exercise reduce smoking rate: relation to oxidative stress status and beta-endorphin release in active smokers.

Authors:  Donrawee Leelarungrayub; Sainatee Pratanaphon; Prapas Pothongsunun; Thanyaluck Sriboonreung; Araya Yankai; Richard J Bloomer
Journal:  J Int Soc Sports Nutr       Date:  2010-05-26       Impact factor: 5.150

5.  Flexible effects of quantified cigarette-smoke delivery on EEG dimensional complexity.

Authors:  W S Pritchard; D G Gilbert; D W Duke
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

6.  The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.

Authors:  D H Malin; J R Lake; V A Carter; J S Cunningham; K M Hebert; D L Conrad; O B Wilson
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530

7.  Plasma nicotine, plasma beta-endorphin and mood states during periods of chronic smoking, abstinence and nicotine replacement.

Authors:  M E Wewers; G A Tejwani; J Anderson
Journal:  Psychopharmacology (Berl)       Date:  1994-09       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.